Cited by 401Cannabis and Cannabinoid ResearchNeurotransmitter Receptor Influence on BehaviorNeuroscience and Neuropharmacology Research

The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.

Brain cannabinoid CB2 receptors modulate cocaine's actions in mice

Open access

Xi, Zheng-Xiong, Peng, Xiao-Qing, Li, Xia, Song, Rui, Zhang, Hai-Ying, Liu, Qing-Rong, Yang, Hong-Ju, Bi, Guo-Hua, Li, Jie, Gardner, Eliot L·2011·Nature Neuroscience

DOI 10.1038/nn.2874PMC PMC3164946

Open this paper in CoChat — free account

Abstract

The presence and function of cannabinoid CB(2) receptors in the brain have been the subjects of much debate. We found that systemic, intranasal or intra-accumbens local administration of JWH133, a selective CB(2) receptor agonist, dose-dependently inhibited intravenous cocaine self-administration, cocaine-enhanced locomotion, and cocaine-enhanced accumbens extracellular dopamine in wild-type and CB(1) receptor knockout (CB(1)(-/-), also known as Cnr1(-/-)) mice, but not in CB(2)(-/-) (Cnr2(-/-)) mice. This inhibition was mimicked by GW405833, another CB(2) receptor agonist with a different chemical structure, and was blocked by AM630, a selective CB(2) receptor antagonist. Intra-accumbens administration of JWH133 alone dose-dependently decreased, whereas intra-accumbens administration of AM630 elevated, extracellular dopamine and locomotion in wild-type and CB(1)(-/-) mice, but not in CB(2)(-/-) mice. Intra-accumbens administration of AM630 also blocked the reduction in cocaine self-administration and extracellular dopamine produced by systemic administration of JWH133. These findings suggest that brain CB(2) receptors modulate cocaine's rewarding and locomotor-stimulating effects, likely by a dopamine-dependent mechanism.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/nn.2874

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Molecular characterization of a peripheral receptor for cannabinoids
Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092
Dopamine, learning and motivation.
Wise, R. A. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1406 · Cited by 3,379 · cited 1×
“JWH133 inhibits cocaine-enhanced extracellular NAc DA Given the crucial role of the mesolimbic DA system in cocaine self-administration and modulation of locomotio”
Background
Identification and Functional Characterization of Brainstem Cannabinoid CB2Receptors
Van Sickle, M. D., Duncan, M., Kingsley, P. J., Mouihate, A., Urbani, P., Mackie, K., Stella, N., Makriyannis, A., Piomelli, D., Davison, J. S., et al. (2005) · Science · doi:10.1126/science.1115740 · Cited by 1,470
Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing efficacy
Richardson, N. R., & Roberts, D. C. S. (1996) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(95)00153-0 · Cited by 1,373
Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice
Zimmer, A., Zimmer, A. M., Hohmann, A. G., Herkenham, M. A., & Bonner, T. I. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5780 · Cited by 1,077
Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain
Glass, M., Faull, R. L. M., & Dragunow, M. (1997) · Neuroscience · doi:10.1016/s0306-4522(96)00428-9 · Cited by 1,052
Cannabinoid CB2 receptors: immunohistochemical localization in rat brain
Gong, J.-P., Onaivi, E. S., Ishiguro, H., Liu, Q.-R., Tagliaferro, P. A., Brusco, A., & Uhl, G. R. (2006) · Brain Research · doi:10.1016/j.brainres.2005.11.035 · Cited by 820
Self-citation
CB2: a cannabinoid receptor with an identity crisis
Atwood, B. K., & Mackie, K. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00729.x · Cited by 658
Cannabinoid Receptors: Where They are and What They do
Mackie, K. (2008) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2008.01671.x · Cited by 638
Intranasal delivery: Physicochemical and therapeutic aspects
Costantino, H. R., Illum, L., Brandt, G., Johnson, P. H., & Quay, S. C. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.03.025 · Cited by 598

Flagged first, then by citations

Show all 50 references

Sorted by citations

Endocannabinoid Signaling and Synaptic Function
Castillo, P. E., Younts, T. J., Chávez, A. E., & Hashimotodani, Y. (2012) · Neuron · doi:10.1016/j.neuron.2012.09.020 · Cited by 1,191
The endocannabinoid system and the brain.
Mechoulam, R., & Parker, L. A. (2013) · Annual Review of Psychology · doi:10.1146/annurev-psych-113011-143739 · Cited by 1,090
Cannabinoids and the expanded endocannabinoid system in neurological disorders
Cristino, L., Bisogno, T., & Di Marzo, V. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-019-0284-z · Cited by 970
Multiple Functions of Endocannabinoid Signaling in the Brain
Katona, I., & Freund, T. F. (2012) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-062111-150420 · Cited by 630
Endocannabinoid signalling in reward and addiction
Parsons, L. H., & Hurd, Y. L. (2015) · Nature reviews. Neuroscience · doi:10.1038/nrn4004 · Cited by 488
Spice drugs are more than harmless herbal blends: A review of the pharmacology and toxicology of synthetic cannabinoids
Seely, K. A., Lapoint, J. M., Moran, J. H., & Fattore, L. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.04.017 · Cited by 463
Cannabis Pharmacology: The Usual Suspects and a Few Promising Leads
Russo, E. B., & Marcu, J. P. (2017) · Advances in pharmacology · doi:10.1016/bs.apha.2017.03.004 · Cited by 403
Cannabinoid Receptors in the Central Nervous System: Their Signaling and Roles in Disease
Kendall, D. A., & Yudowski, G. A. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00294 · Cited by 388
Endocannabinoids and endocannabinoid-related mediators: Targets, metabolism and role in neurological disorders
Iannotti, F. A., Marzo, V. D., & Petrosino, S. (2016) · Progress in Lipid Research · doi:10.1016/j.plipres.2016.02.002 · Cited by 373
Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities
Pertwee, R. G. (2012) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2011.0381 · Cited by 351
Endocannabinoid signaling, glucocorticoid-mediated negative feedback, and regulation of the hypothalamic-pituitary-adrenal axis
Hill, M. N., & Tasker, J. G. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.12.030 · Cited by 346
Cannabinoid CB 2 receptors modulate midbrain dopamine neuronal activity and dopamine-related behavior in mice
Zhang, H.-Y., Gao, M., Liu, Q.-R., Bi, G.-H., Li, X., Yang, H.-J., Gardner, E. L., Wu, J., & Xi, Z.-X. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1413210111 · Cited by 334
Self-citation
The Case for the Entourage Effect and Conventional Breeding of Clinical Cannabis: No “Strain,” No Gain
Russo, E. B. (2019) · Frontiers in Plant Science · doi:10.3389/fpls.2018.01969 · Cited by 345
Sex differences in cannabinoid pharmacology: A reflection of differences in the endocannabinoid system?
Craft, R. M., Marusich, J. A., & Wiley, J. L. (2012) · Life Sciences · doi:10.1016/j.lfs.2012.06.009 · Cited by 301
Cannabinoid Type 2 Receptors Mediate a Cell Type-Specific Plasticity in the Hippocampus
Stempel, A. V., Stumpf, A., Zhang, H., ÖZDOĞAN, T., Pannasch, U., Theis, A.-K., Otte, D.-M., Wojtalla, A., Rácz, I., Ponomarenko, A. A., et al. (2016) · Neuron · doi:10.1016/j.neuron.2016.03.034 · Cited by 304
Self-citation
Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to Δ9-THC: Mechanism underlying greater toxicity?
Fantegrossi, W. E., Moran, J. H., Radominska-p, A., & Prather, P. L. (2013) · Life Sciences · doi:10.1016/j.lfs.2013.09.017 · Cited by 261
Medicinal Properties of Cannabinoids, Terpenes, and Flavonoids in Cannabis, and Benefits in Migraine, Headache, and Pain: An Update on Current Evidence and Cannabis Science
Baron, E. P. (2018) · Headache The Journal of Head and Face Pain · doi:10.1111/head.13345 · Cited by 268
Synaptic functions of endocannabinoid signaling in health and disease
Araque, A., Castillo, P. E., Manzoni, O. J., & Tonini, R. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.06.017 · Cited by 252
Cannabinoid Receptors CB1 and CB2 Form Functional Heteromers in Brain
Callén, L., Moreno, E., Barroso‐Chinea, P., Moreno‐Delgado, D., Cortés, A., Mallol, J., Casadó, V., Lanciego, J. L., Franco, R., Lluís, C., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.335273 · Cited by 251
Amygdala FAAH and anandamide: mediating protection and recovery from stress
Gunduz-Cinar, O., Hill, M. N., McEwen, B. S., & Holmes, A. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2013.08.008 · Cited by 229
Epigenetic Effects of Cannabis Exposure
Szutorisz, H., & Hurd, Y. L. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.09.014 · Cited by 221
Brain cannabinoid receptor 2: expression, function and modulation
Chen, D., Gao, M., Gao, F., Quan-xi, S., & Wu, J. (2017) · Acta Pharmacologica Sinica · doi:10.1038/aps.2016.149 · Cited by 216
An overview of the cannabinoid type 2 receptor system and its therapeutic potential
Bie, B., Wu, J., Foss, J. F., & Naguib, M. (2018) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0000000000000616 · Cited by 227
Neuropathology of substance use disorders
Cadet, J. L., Bisagno, V., & Milroy, C. M. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1221-7 · Cited by 217
Chronic Cannabinoid Receptor 2 Activation Reverses Paclitaxel Neuropathy Without Tolerance or Cannabinoid Receptor 1–Dependent Withdrawal
Deng, L., Guindon, J., Cornett, B., Makriyannis, A., Mackie, K., & Hohmann, A. G. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.04.009 · Cited by 200
Progress in brain cannabinoid CB2 receptor research: From genes to behavior
Jordan, C. J., & Xi, Z. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.12.026 · Cited by 207
Self-citation
Pharmacological Foundations of Cannabis Chemovars
Lewis, M. A., Russo, E. B., & Smith, K. (2017) · Planta Medica · doi:10.1055/s-0043-122240 · Cited by 192
Excitability of prefrontal cortical pyramidal neurons is modulated by activation of intracellular type-2 cannabinoid receptors
den Boon, F. S., Chameau, P. J. P., Schaafsma-Zhao, Q., van Aken, W., Bari, M., Oddi, S., Kruse, C. G., Maccarrone, M., Wadman, W. J., & Werkman, T. R. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1118167109 · Cited by 190
Cannabis sativa and Hemp
Hartsel, J. A., Eades, J., Hickory, B., & Makriyannis, A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802147-7.00053-x · Cited by 204
Endocannabinoid modulation of dopamine neurotransmission
Covey, D. P., Mateo, Y., Sulzer, D., Cheer, J. F., & Lovinger, D. M. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.04.033 · Cited by 197
Cannabidiol (CBD) use in psychiatric disorders: A systematic review
Bonaccorso, S., Ricciardi, A., Zangani, C., Chiappini, S., & Schifano, F. (2019) · NeuroToxicology · doi:10.1016/j.neuro.2019.08.002 · Cited by 180
Early Phase in the Development of Cannabidiol as a Treatment for Addiction: Opioid Relapse Takes Initial Center Stage
Hurd, Y. L., Yoon, M. J., Manini, A. F., Hernandez, S. H., Olmedo, R., Östman, M., & Jutras‐Aswad, D. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0373-7 · Cited by 171
CB2 Receptor in Microglia: The Guardian of Self-Control
Komorowska‐Müller, J. A., & Schmöle, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010019 · Cited by 176
Activation of Cannabinoid CB2 Receptor–Mediated AMPK/CREB Pathway Reduces Cerebral Ischemic Injury
Choi, I.-Y., Ju, C., Jalin, A. M. A. A., Lee, D. I., Prather, P. L., & Kim, W.-K. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.11.024 · Cited by 157
Expression of functional cannabinoid CB 2 receptor in VTA dopamine neurons in rats
Zhang, H., Gao, M., Shen, H., Bi, G., Yang, H., Liu, Q., Wu, J., Gardner, E. L., Bonci, A., & Xi, Z. (2016) · Addiction Biology · doi:10.1111/adb.12367 · Cited by 156
Self-citation
Functional Selectivity in CB2 Cannabinoid Receptor Signaling and Regulation: Implications for the Therapeutic Potential of CB2 Ligands
Atwood, B. K., Wager‐Miller, J., Haskins, C. P., Straiker, A. J., & Mackie, K. (2011) · Molecular Pharmacology · doi:10.1124/mol.111.074013 · Cited by 152
Endocannabinoid Regulation of Reward and Reinforcement through Interaction with Dopamine and Endogenous Opioid Signaling
Wenzel, J. M., & Cheer, J. F. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.126 · Cited by 161
Mechanisms of Action and Persistent Neuroplasticity by Drugs of Abuse
Korpi, E. R., den Hollander, B., Farooq, U., Vashchinkina, E., Rajkumar, R., Nutt, D. J., Hyytiä, P., & Dawe, G. S. (2015) · Pharmacological Reviews · doi:10.1124/pr.115.010967 · Cited by 148
Cannabinoid type 2 receptors in dopamine neurons inhibits psychomotor behaviors, alters anxiety, depression and alcohol preference
Liu, Q.-R., Canseco-Alba, A., Zhang, H.-Y., Tagliaferro, P., Chung, M., Dennis, E., Sanabria, B., Schanz, N., Escosteguy-Neto, J. C., Ishiguro, H., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-17796-y · Cited by 147
Self-citation
Neuronal expression of CB2 cannabinoid receptor mRNAs in the mouse hippocampus
Li, Y., & Kim, J. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.10.041 · Cited by 148
Antipsychotic-like Effects of M 4 Positive Allosteric Modulators Are Mediated by CB 2 Receptor-Dependent Inhibition of Dopamine Release
Foster, D. J., Wilson, J. M., Remke, D. H., Mahmood, M. S., Uddin, M. J., Wess, J., Patel, S., Marnett, L. J., Niswender, C. M., Jones, C. K., et al. (2016) · Neuron · doi:10.1016/j.neuron.2016.08.017 · Cited by 146
Turning Over a New Leaf: Cannabinoid and Endocannabinoid Modulation of Immune Function
Cabral, G. A., Rogers, T. J., & Lichtman, A. H. (2015) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-015-9615-z · Cited by 146
Cannabidiol inhibits the reward‐facilitating effect of morphine: involvement of 5‐HT1A receptors in the dorsal raphe nucleus
Katsidoni, V., Anagnostou, I., & Panagis, G. (2012) · Addiction Biology · doi:10.1111/j.1369-1600.2012.00483.x · Cited by 132
Interactions of the opioid and cannabinoid systems in reward: Insights from knockout studies
Befort, K. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00006 · Cited by 139
Species Differences in Cannabinoid Receptor 2 and Receptor Responses to Cocaine Self-Administration in Mice and Rats
Zhang, H., Bi, G., Li, X., Li, J., Qu, H., Zhang, S.-J., Li, C., Onaivi, E. S., Gardner, E. L., Xi, Z., et al. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.297 · Cited by 134
Self-citation
Zebrafish: a model for the study of addiction genetics
Klee, E. W., Schneider, H., Clark, K. J., Cousin, M. A., Ebbert, J. O., Hooten, W. M., Karpyak, V. M., Warner, D. O., & Ekker, S. C. (2011) · Human Genetics · doi:10.1007/s00439-011-1128-0 · Cited by 130
Pharmacological and Toxicological Effects of Synthetic Cannabinoids and Their Metabolites
Tai, S., & Fantegrossi, W. E. (2016) · Current topics in behavioral neurosciences · doi:10.1007/7854_2016_60 · Cited by 127
Synthetic Cannabinoids: Pharmacology, Behavioral Effects, and Abuse Potential
Tai, S., & Fantegrossi, W. E. (2014) · Current Addiction Reports · doi:10.1007/s40429-014-0014-y · Cited by 134
Synaptic plasticity alterations associated with memory impairment induced by deletion of CB2 cannabinoid receptors
García‐Gutiérrez, M. S., Ortega-Álvaro, A., Busquets-García, A., Pérez‐Ortiz, J. M., Caltana, L. R., Ricatti, M. J., Brusco, A., Maldonado, R. J., & Manzanares, J. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.05.034 · Cited by 126
Role of CB2 Cannabinoid Receptors in the Rewarding, Reinforcing, and Physical Effects of Nicotine
Navarrete, F., Rodríguez‐Arias, M., Martín‐García, E., Navarro, D., García‐Gutiérrez, M. S., Aguilar, M. A., Aracil-Fernández, A., Berbel, P. J., Miñarro, J., Maldonado, R. J., et al. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.157 · Cited by 122
The cannabinoid receptor 2 agonist, β-caryophyllene, reduced voluntary alcohol intake and attenuated ethanol-induced place preference and sensitivity in mice
Mansouri, S. A., Ojha, S. K., Maamari, E. A., Ameri, M. A., Nurulain, S. M., & Bahí, A. (2014) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2014.06.025 · Cited by 119
Natural Compounds as Medical Strategies in the Prevention and Treatment of Psychiatric Disorders Seen in Neurological Diseases
Akkol, E. K., Çankaya, İ. İ. T., Karatoprak, G. Ş., Çarpar, E., Sobarzo‐Sánchez, E., & Capasso, R. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.669638 · Cited by 128
Decreased Cocaine Motor Sensitization and Self-Administration in Mice Overexpressing Cannabinoid CB2 Receptors
Aracil-Fernández, A., Trigo, J. M., García‐Gutiérrez, M. S., Ortega-Álvaro, A., Ternianov, A., Navarro, D., Robledo, P., Berbel, P. J., Maldonado, R. J., & Manzanares, J. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.22 · Cited by 119
Current evidence of cannabinoid‐based analgesia obtained in preclinical and human experimental settings
Lötsch, J., Weyer-Menkhoff, I., & Tegeder, I. (2017) · European Journal of Pain · doi:10.1002/ejp.1148 · Cited by 123
Role of the endocannabinoid system in drug addiction
Manzanares, J., Cabañero, D., Puente, N., García‐Gutiérrez, M. S., Grandes, P., & Maldonado, R. J. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.09.013 · Cited by 118
Cannabidiol attenuates the rewarding effects of cocaine in rats by CB2, 5-HT1A and TRPV1 receptor mechanisms
Galaj, E., Bi, G., Yang, H.-J., & Xi, Z. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.107740 · Cited by 114
Self-citation
Inhibition of FAAH and activation of PPAR: New approaches to the treatment of cognitive dysfunction and drug addiction
Panlilio, L. V., Justinová, Z., & Goldberg, S. R. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.01.003 · Cited by 106
Brain activity of anandamide: a rewarding bliss?
Scherma, M., Masia, P., Satta, V., Fratta, W., Fadda, P., & Tanda, G. (2018) · Acta Pharmacologica Sinica · doi:10.1038/s41401-018-0075-x · Cited by 110
Endocannabinoid System: the Direct and Indirect Involvement in the Memory and Learning Processes—a Short Review
Kruk-Słomka, M., Dzik, A., Budzyńska, B., & Biała, G. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0313-5 · Cited by 117
FAAH Gene Variation Moderates Stress Response and Symptom Severity in Patients with Posttraumatic Stress Disorder and Comorbid Alcohol Dependence
Spagnolo, P. A., Ramchandani, V. A., Schwandt, M. L., Kwako, L. E., George, D. T., Mayo, L. M., Hillard, C. J., & Heilig, M. A. (2016) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.13210 · Cited by 112
Deconstructing the neurobiology of cannabis use disorder
Ferland, J. N., & Hurd, Y. L. (2020) · Nature Neuroscience · doi:10.1038/s41593-020-0611-0 · Cited by 104
Spice/K2 drugs – more than innocent substitutes for marijuana
Zawilska, J. B., & Wojcieszak, J. (2013) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713001247 · Cited by 98
Synergistic attenuation of chronic pain using mu opioid and cannabinoid receptor 2 agonists
Grenald, S. A., Young, M. A., Wang, Y., Ossipov, M. H., Ibrahim, M. M., Largent-Milnes, T. M., & Vanderah, T. W. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.12.008 · Cited by 97
Glucagon-like peptide 1 receptor activation regulates cocaine actions and dopamine homeostasis in the lateral septum by decreasing arachidonic acid levels
Reddy, I. A., Pino, J. A., Weikop, P., Osses, N., Sørensen, G., Bering, T., Valle, C., Bluett, R. J., Erreger, K., Wortwein, G., et al. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.86 · Cited by 96
Dissecting the Role of GABA Neurons in the VTA versus SNr in Opioid Reward
Galaj, E., Han, X., Shen, H., Jordan, C. J., He, Y., Humburg, B. A., Bi, G., & Xi, Z. (2020) · Journal of Neuroscience · doi:10.1523/jneurosci.0988-20.2020 · Cited by 97
Self-citation
Ventral Tegmental Area Cannabinoid Type-1 Receptors Control Voluntary Exercise Performance
Dubreucq, S., Durand, A., Matias, I., Bénard, G., Richard, É. M., Gómez, E. S., Glangetas, C., Groc, L., Wadleigh, A., Massa, F., et al. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.10.025 · Cited by 95
CB2 Cannabinoid Receptor Knockout in Mice Impairs Contextual Long-Term Memory and Enhances Spatial Working Memory
Li, Y., & Kim, J. (2015) · Neural Plasticity · doi:10.1155/2016/9817089 · Cited by 90
Human metabolites of synthetic cannabinoids JWH-018 and JWH-073 bind with high affinity and act as potent agonists at cannabinoid type-2 receptors
Rajasekaran, M., Brents, L. K., Franks, L. N., Moran, J. H., & Prather, P. L. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.03.012 · Cited by 90
Effect of the novel synthetic cannabinoids AKB48 and 5F-AKB48 on “tetrad”, sensorimotor, neurological and neurochemical responses in mice. In vitro and in vivo pharmacological studies
Canazza, I., Ossato, A., Trapella, C., Fantinati, A., Luca, M. A. D., Margiani, G., Vincenzi, F., Rimondo, C., Rosa, F. D., Gregori, A., et al. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4402-y · Cited by 89
The endocannabinoid system as a target for addiction treatment: Trials and tribulations
Sloan, M. E., Gowin, J. L., Ramchandani, V. A., Hurd, Y. L., & Foll, B. L. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.05.031 · Cited by 94
Stimulation of in vivo dopamine transmission and intravenous self-administration in rats and mice by JWH-018, a Spice cannabinoid
Luca, M. A. D., Bimpisidis, Z., Melis, M., Marti, M., Caboni, P., Valentini, V., Margiani, G., Pintori, N., Polis, I. Y., Marsicano, G., et al. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.08.041 · Cited by 88
The endocannabinoid system mediates aerobic exercise-induced antinociception in rats
Galdino, G. S., Romero, T. R. L., Silva, J. F. P., de Aguiar, D. C., de Paula, A. M., Cruz, J. S., Parrella, C., Piscitelli, F., Duarte, I. D. G., Marzo, V. D., et al. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.09.022 · Cited by 88
Functional Selectivity of CB2 Cannabinoid Receptor Ligands at a Canonical and Noncanonical Pathway
Dhopeshwarkar, A., & Mackie, K. (2016) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.116.232561 · Cited by 88
The cannabinoid CB2 receptor is necessary for nicotine-conditioned place preference, but not other behavioral effects of nicotine in mice
Ignatowska-Jankowska, B. M., Muldoon, P. P., Lichtman, A. H., & Damaj, M. I. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3117-6 · Cited by 88
Marijuana, endocannabinoids, and epilepsy: Potential and challenges for improved therapeutic intervention
Hofmann, M. E., & Frazier, C. J. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.11.047 · Cited by 83
Beyond the CB1 Receptor: Is Cannabidiol the Answer for Disorders of Motivation?
Zlebnik, N. E., & Cheer, J. F. (2016) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-070815-014038 · Cited by 82
Distinct roles of neuronal and microglial CB2 cannabinoid receptors in the mouse hippocampus
Li, Y., & Kim, J. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.08.053 · Cited by 78
Deletion of CB 2 cannabinoid receptors reduces synaptic transmission and long‐term potentiation in the mouse hippocampus
Li, Y., & Kim, J. (2015) · Hippocampus · doi:10.1002/hipo.22558 · Cited by 78
Response dynamics of midbrain dopamine neurons and serotonin neurons to heroin, nicotine, cocaine, and MDMA
Wei, C. K., Han, X., Weng, D., Feng, Q., Qi, X., Li, J., & Luo, M. (2018) · Cell Discovery · doi:10.1038/s41421-018-0060-z · Cited by 79
Self-citation
CB2: Therapeutic target-in-waiting
Atwood, B. K., Straiker, A. J., & Mackie, K. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.12.001 · Cited by 76
Increased vulnerability to cocaine in mice lacking dopamine D 3 receptors
Song, R., Zhang, H., Li, X., Bi, G., Gardner, E. L., & Xi, Z. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1205297109 · Cited by 82
Self-citation
Effect of JWH-250, JWH-073 and their interaction on “tetrad”, sensorimotor, neurological and neurochemical responses in mice
Ossato, A., Canazza, I., Trapella, C., Vincenzi, F., Luca, M. A. D., Rimondo, C., Varani, K., Borea, P. A., Serpelloni, G., & Marti, M. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2016.01.007 · Cited by 75
Aggregated single-walled carbon nanotubes attenuate the behavioural and neurochemical effects of methamphetamine in mice
Xue, X., Yang, J., He, Y., Wang, L., Liu, P., Yu, L., Bi, G., Zhu, M., Liu, Y., Xiang, R., et al. (2016) · Nature Nanotechnology · doi:10.1038/nnano.2016.23 · Cited by 74
Self-citation
Mechanisms of Cannabinoid CB2 Receptor-Mediated Reduction of Dopamine Neuronal Excitability in Mouse Ventral Tegmental Area
Ma, Z., Gao, F., Larsen, B., Gao, M., Luo, Z., Chen, D., Ma, X., Qiu, S., Zhou, Y., Xie, J., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.03.040 · Cited by 74
Self-citation
The nucleus accumbens in reward and aversion processing: insights and implications
Xu, Y., Lin, Y., Yu, M., & Zhou, K. (2024) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2024.1420028 · Cited by 86
Cannabinoid modulation of drug reward and the implications of marijuana legalization
Covey, D. P., Wenzel, J. M., & Cheer, J. F. (2014) · Brain Research · doi:10.1016/j.brainres.2014.11.034 · Cited by 75
Antibody testing for brain immunohistochemistry: Brain immunolabeling for the cannabinoid CB2 receptor
Baek, J., Darlington, C. L., Smith, P. F., & Ashton, J. C. (2013) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2013.03.021 · Cited by 71
Cannabinoid CB1 and CB2 receptor mechanisms underlie cannabis reward and aversion in rats
Spiller, K. J., Bi, G., He, Y., Galaj, E., Gardner, E. L., & Xi, Z. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14625 · Cited by 67
Self-citation
CB2 receptor in the CNS: From immune and neuronal modulation to behavior
Grabon, W., Rheims, S., Smith, J., Bodennec, J., Belmeguenaï, A., & Bezin, L. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105226 · Cited by 67
Time-Dependent Protection of CB2 Receptor Agonist in Stroke
Yu, S., Reiner, D. J., Shen, H., Wu, K., Liu, Q., & Wang, Y. (2015) · PLoS ONE · doi:10.1371/journal.pone.0132487 · Cited by 66
Self-citation
Effects of a Selective Cannabinoid CB2 Agonist and Antagonist on Intravenous Nicotine Self Administration and Reinstatement of Nicotine Seeking
Gamaleddin, I., Zvonok, A. M., Makriyannis, A., Goldberg, S. R., & Foll, B. L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029900 · Cited by 66
Expression Analysis of CB2-GFP BAC Transgenic Mice
Schmöle, A., Lundt, R., Gennequin, B., Schrage, H., Beins, E. C., Krämer, A., Zimmer, T. S., Limmer, A., Zimmer, A., & Otte, D.-M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0138986 · Cited by 64
Potential of Cannabinoid Receptor Ligands as Treatment for Substance Use Disorders
Galaj, E., & Xi, Z. (2019) · CNS Drugs · doi:10.1007/s40263-019-00664-w · Cited by 69
Self-citation
New Insights and Potential Therapeutic Targeting of CB2 Cannabinoid Receptors in CNS Disorders
Kibret, B. G., Ishiguro, H., Horiuchi, Y., & Onaivi, E. S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020975 · Cited by 69
The Neurotherapeutic Arsenal in Cannabis sativa: Insights into Anti-Neuroinflammatory and Neuroprotective Activity and Potential Entourage Effects
Al-Khazaleh, A. K., Zhou, X., Bhuyan, D. J., Münch, G. W., Al-Dalabeeh, E. A., Jaye, K. M., & Chang, D. (2024) · Molecules · doi:10.3390/molecules29020410 · Cited by 66
2012 Division of Medicinal Chemistry Award Address. Trekking the Cannabinoid Road: A Personal Perspective
Makriyannis, A. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500220s · Cited by 61
Cannabinoids Inhibit T-cells via Cannabinoid Receptor 2 in an In Vitro Assay for Graft Rejection, the Mixed Lymphocyte Reaction
Robinson, R. H., Meissler, J. J., Deckman, J. M., Gaughan, J. P., Adler, M. W., & Eisenstein, T. K. (2013) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-013-9485-1 · Cited by 60
Latest Advances in Novel Cannabinoid Cb2Ligands for Drug Abuse and Their Therapeutic Potential
Yang, P., Wang, L., & Xie, X.-Q. (2012) · Future Medicinal Chemistry · doi:10.4155/fmc.11.179 · Cited by 58
Regulation of Brain Reward by the Endocannabinoid System: A Critical Review of Behavioral Studies in Animals
Vlachou, S., & Panagis, G. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990433 · Cited by 62
Behavioral effects of psychostimulants in mutant mice with cell-type specific deletion of CB2 cannabinoid receptors in dopamine neurons
Canseco-Alba, A., Schanz, N., Sanabria, B., Zhao, J., Lin, Z., Liu, Q., & Onaivi, E. S. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2018.11.043 · Cited by 59
Self-citation

Authors: Xi, Z.-X., Peng, X.-Q., Li, X., Song, R., Zhang, H.-Y., Liu, Q.-R., Yang, H.-J., Bi, G.-H., Li, J., & Gardner, E. L.
Affiliations: National Institute on Drug Abuse (US)
Corresponding author: Xi, Zheng-Xiong
ORCID: Xi, Zheng-Xiong
Peng, Xiao-Qing
Li, Xia
Song, Rui
Zhang, Hai-Ying
Liu, Qing-Rong
Bi, Guo-Hua
Li, Jie
Gardner, Eliot L
Venue: Nature Neuroscience
Publisher: Springer Science and Business Media LLC
Published: 2011-07-24
Volume: 14
Issue: 9
Pages: 1160-1166
ISSN: 1097-6256 (ISSN-L)
1546-1726
DOI: 10.1038/nn.2874
PMC: PMC3164946
OpenAlex: W1989353122
Cited by: 397
References: 50
Citations by year: 2026: 9 · 2025: 13 · 2024: 14 · 2023: 16 · 2022: 30 · 2021: 34 · 2020: 23 · 2019: 27 · 2018: 25 · 2017: 31 · 2016: 30 · 2015: 27 · 2014: 37 · 2013: 35 · 2012: 37
FWCI: 28.11
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
Locations: Nature Neuroscience (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institutes of Health (Z99 DA999999)
Topics: Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords: CB2 receptor, cocaine self-administration, nucleus accumbens, JWH-133, AM630, dopamine, drug reward, CB2 receptor agonist
MeSH terms: Administration, Intranasal, Analysis of Variance, Animals, Brain, Cannabinoids, Cocaine, Conditioning, Operant, Indoles, Male, Mice, Inbred C57BL, Motor Activity, Self Administration, Microdialysis, Mice, Knockout, Dopamine Uptake Inhibitors, Receptor, Cannabinoid, CB1, Receptor, Cannabinoid, CB2, Rotarod Performance Test, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Brain cannabinoid CB2 receptors modulate cocaine's actions in mice

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks